Labcorp
About: Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Employees: 70,000
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
29% more funds holding in top 10
Funds holding in top 10: 7 [Q3] → 9 (+2) [Q4]
20% more first-time investments, than exits
New positions opened: 108 | Existing positions closed: 90
6% more capital invested
Capital invested by funds: $16.8B [Q3] → $17.8B (+$1.06B) [Q4]
3.4% more ownership
Funds ownership: 89.6% [Q3] → 93.0% (+3.4%) [Q4]
0% more repeat investments, than reductions
Existing positions increased: 334 | Existing positions reduced: 333
0% less funds holding
Funds holding: 907 [Q3] → 905 (-2) [Q4]
29% less call options, than puts
Call options by funds: $48.5M | Put options by funds: $68.4M
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$250
2%
upside
Avg. target
$277
13%
upside
High target
$300
22%
upside
6 analyst ratings
4 positive
67%
2 neutral
33%
0 negative
0%
Truist Securities David Macdonald 61% 1-year accuracy 61 / 100 met price target | 18%upside $290 | Buy Maintained | 12 May 2025 |
Piper Sandler David Westenberg 52% 1-year accuracy 24 / 46 met price target | 14%upside $280 | Neutral Maintained | 6 May 2025 |
Barclays Jack Meehan 0 / 0 met price target | 2%upside $250 | Equal-Weight Maintained | 30 Apr 2025 |
Baird Eric Coldwell 50% 1-year accuracy 14 / 28 met price target | 8%upside $267 | Outperform Maintained | 30 Apr 2025 |
Redburn Atlantic Jamie Clark 75% 1-year accuracy 3 / 4 met price target | 12%upside $276 | Buy Initiated | 2 Apr 2025 |
Financial journalist opinion
Based on 15 articles about LH published over the past 30 days
Positive
Zacks Investment Research
16 hours ago
Here's Why Labcorp (LH) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Positive
Zacks Investment Research
2 days ago
3 Dental Supplies Stocks Likely to Gain From US-China Trade Deal
Here we discuss three stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, LH and ALGN.
Positive
Zacks Investment Research
3 days ago
Should Value Investors Buy Labcorp (LH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
PRNewsWire
1 week ago
Labcorp to Webcast Its Annual Meeting of Shareholders May 15
BURLINGTON, N.C., May 8, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 15 at 9:00 a.m.
Neutral
Zacks Investment Research
1 week ago
LH vs. MMSI: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Labcorp (LH) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
Positive
Zacks Investment Research
2 weeks ago
Why Labcorp (LH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Neutral
Seeking Alpha
2 weeks ago
Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript
Labcorp Holdings Inc. (NYSE:LH ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Christin O'Donnell - Investor Relations Adam Schechter - Chairman & Chief Executive Officer Julia Wang - Executive Vice President & Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Ann Hynes - Mizuho Securities Erin Wright - Morgan Stanley Elizabeth Anderson - Evercore ISI Lisa Gill - JPMorgan Jack Meehan - Nephron Research Luke Sergott - Barclays Kevin Caliendo - UBS Michael Ryskin - Bank of America Patrick Donnelly - Citi Eric Coldwell - Baird Kieran Ryan - Deutsche Bank Operator Good day and thank you for standing by. Welcome to the Q1 2025 Labcorp Holdings Earnings Conference Call.
Positive
Zacks Investment Research
2 weeks ago
Labcorp (LH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Positive
Zacks Investment Research
2 weeks ago
Labcorp Q1 Earnings Surpass Estimates, Revenues Miss, Stock Gains
LH delivers better-than-expected earnings in the first quarter of 2025.
Positive
Zacks Investment Research
2 weeks ago
Labcorp (LH) Beats Q1 Earnings Estimates
Labcorp (LH) came out with quarterly earnings of $3.84 per share, beating the Zacks Consensus Estimate of $3.73 per share. This compares to earnings of $3.68 per share a year ago.
Charts implemented using Lightweight Charts™